chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes. Left underarm and left lower leg (between the knee and foot on the back side of the leg); This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 16Apr2021 at 17:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, fatty liver, overweight and occasional palpitations. The patient was not allergic to medications, food, or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), lecithin (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D3) and zinc (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 17:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 13:00, the patient experienced swollen lymph nodes in left underarm and left lower leg between the knee and foot on the back side of the leg. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen lymph nodes in left underarm and left lower leg between the knee and foot on the back side of the leg was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Skin burning sensation, Vaccination site pain
Clinical narrative: Intense pins needles in right fingertips burning up to elbow; Intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 13:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown whether the patient have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 17Apr2021 at 03:00, the patient experienced intense pins needles in right hand and fingers, lasted 30 minutes subsided with only expected soreness at injection site. On 18Apr2021 at 19:00, the patient experienced intense pins needles in right fingertips burning up to elbow lasting 2 hours and continuing. It was reported that began 30 minutes after doing homework, right-handed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow and soreness at injection site were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. It was unknown whether the patient received any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 18Apr2021 at 14:44, 10 days after the vaccination, the patient experienced arm soreness. No therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event arm soreness was recovered on 18Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Paraesthesia, Sensory loss, Taste disorder
Clinical narrative: Lost of sensation in nose and lips for several hours; rubber taste in mouth; Tingling in back and shoulders; Fatigue; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included citalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 17:45, the patient experienced loss of sensation in his nose and lips for several hours, rubber taste in mouth for 14-16 hours, tingling in his back and shoulders, fatigue and soreness. It was reported that fatigue and soreness were still occurred 2 days after vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Any therapeutic measures were not taken as a result of the events. The clinical outcome of the events loss of sensation in nose and lips for several hours, rubber taste in mouth and tingling in back and shoulders was recovered with sequelae on an unknown date in Apr2021. The clinical outcome of the events fatigue and soreness was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizzy; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and penicillin allergy. Concomitant medications included levothyroxine sodium (LEVOTHROID) and colecalciferol, calcium (CALTRATE BONE HEALTH) and multivitamins; all taken for unspecified indication from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 13:00, after 6 days of first dose, the patient became dizzy, had nausea, really bad dizziness which lasted for 3 days, stayed in bed mostly, the fourth day the patient felt better, almost normal, the next morning the patient woke up dizzy again and had to stay mostly in bed for another 2 days. The patient was healthy, exercise every day. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizzy and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Pains on the right side of body.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date at 14:00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetic and allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. On 31Mar2021, the patient experienced pains on the right side of body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event pains on the right side of body and included treatment with ibuprofen 800 mg. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pains on the right side of body was unknown at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Experiencing pain on my right side, middle of the back; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 18Apr2021 at 09:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Apr2021 at 00:00, the patient was experiencing pain on right side, middle of the back. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event experiencing pain on right side, middle of the back was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Maternal exposure during pregnancy
Clinical narrative: Metal taste in my mouth; maternal exposure during pregnancy, first trimester; This is a spontaneous report from a contactable consumer (patient). This consumer or other non hcp reported information for mother. This is a maternal report.  A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in left arm on 15Apr2021 09:45 (at the age of 39-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Patient had no known allergies to medications, food or other products. Concomitant medication included prenatal supplements for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The last menstrual period was on 26Feb2021. On 15Apr2021 at 21:00, the patient experienced metallic taste in mouth. Since the patient had received the vaccine during pregnancy there was maternal exposure during pregnancy, first trimester. Patient was 7 weeks pregnant at the onset of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Patient was due to deliver on 03Dec2021. The clinical outcome of the event metallic taste was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Two days after receiving the Pfizer vaccine in my left arm, I've been experiencing a burning sensation (which comes and goes) on the side of my left breast. It lasts for a few seconds then subsides. It happens about 5 times per day.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0164) via an unspecified route of administration in the left arm on 15Apr2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included lysine 500 milligram (MANUFACTURER UNKNOWN), metoprolol 25 milligram (MANUFACTURER UNKNOWN), colecalciferol (D3 5000), colecalciferol (D3 5000) and minerals nos, vitamins nos (CENTRUM); all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 17Apr2021 at 12:00, two days after receiving the Pfizer vaccine in her left arm, the patient has been experiencing a burning sensation (which comes and goes) on the side of her left breast. It lasts for a few seconds then subsides. It happens about five times per day. The day of report was the third day she has been experiencing this feeling. The patient hoped the shot hadn't caused any internal problems and it goes away soon. The patient was hesitant about the second shot, for sure. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event two days after receiving the Pfizer vaccine in her left arm, the patient has been experiencing a burning sensation (which comes and goes) on the side of her left breast; it lasts for a few seconds then subsides; it happens about five times per day; the day of report was the third day she has been experiencing this feeling was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pain in jaw
Clinical narrative: Pain while eating or yawning; Pain under left ear / jaw.; Pain while yawning; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 20Mar2021 at 11:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, after two weeks, the patient experienced pain while eating or yawning and pain under left ear/jaw. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with unspecified pain killers. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain while eating or yawning and pain under left ear/jaw was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Monoparesis, Pain, X-ray
Clinical narrative: Lost complete uses of left arm from shoulder to elbow. Could not lift arm from side, overhead.; Pain throbbing pain with a pulse from arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 04Apr2021 at 12:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and NATURE BOUNTY HAIR, SKIN, NAIL VIT both for unspecified indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 00:00, on tenth day after vaccine the patient lost complete use of left arm from shoulder to elbow, could not lift arm from side, overhead and pain throbbing pain with a pulse from arm. She waited for two days in pain and went to urgent care. On 17Apr2021, the patient underwent test which include X-ray to see if something strange, even though no new activity and nothing was found. She was advised to continue taking over the counter ibuprofen (MANUFACTURER UNKNOWN). Arm was still not 100 percent limited use at best and throbbing had subsided. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as the result of events and included treatment with steroid injection (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcome of the events lost complete use of left arm from shoulder to elbow, could not lift arm from side, overhead was not recovered ; while that of pain throbbing, pain with a pulse from arm was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Feeling of body temperature change, Headache
Clinical narrative: Brain fog; Dizziness; Headache; Fatigue; Nausea; Bodily muscle aches; Bodily muscle spasms; Erratic temperatures (hot and cold); This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 07Apr2021 at 13:45 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included tendonitis, milk allergy, allergy to wheat, tomatoes allergy, latex allergy, and sulfonamide allergy. The patient previously took erythromycin (MANUFACTURER UNKNOWN) on an unknown date and for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:00, about 26 hours after the vaccine, the patient experienced brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold). The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold) were resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Nausea
Clinical narrative: Brain fog; Dizziness; Headache; Fatigue; Nausea; Bodily muscle aches; Bodily muscle spasms; Erratic temperatures (hot and cold); This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 07Apr2021 at 13:45 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included tendonitis, milk allergy, allergy to wheat, tomatoes allergy, latex allergy, and sulfonamide allergy. The patient previously took erythromycin (MANUFACTURER UNKNOWN) on an unknown date and for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:00, about 26 hours after the vaccine, the patient experienced brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold). The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold) were resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia
Clinical narrative: Nerve pain on side of right face; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 12:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis and migraines. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included secukinumab (COSENTYX), sumatriptan succinate (SUMATRIPTAN), promethazine (PHENERGAN), galcanezumab (EMGALITY) and metoclopramide hydrochloride (PROMET); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 12:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 19:30, the patient experienced nerve pain on side of the right face and the pain came on after the second dose about 29 hours after (as reported). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event nerve pain on side of the right face was unknown at the time of the report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Hyperhidrosis, Influenza like illness
Clinical narrative: Sweating; Maternal exposure during pregnancy , gestational age 3 week; Dizzy and lightheaded within 5 minutes of receiving - this lasted about 3 days.; Vaccine burned when being injected; Arm was so sore  ,couldn't raise it above my shoulder for 4 days; Chills; I felt like I had the flu.; Nauseous; So very tired; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0100 and Expiry date was not reported), via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 42-year-old) as dose 1, single dose for COVID-19 immunisation. The patient was pregnant at time of vaccination. Medical history included asthma and fibromyalgia from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient's last menstrual date was on 06Mar2021 and delivery was due on 11Dec2021. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously took sulfamethoxazole (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the patient had received the vaccine during pregnancy there was maternal exposure during pregnancy, first trimester. On 01Apr2021 at 15:30 the patient experienced dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, arm was so sore and couldn't raise it above shoulder for 4 days. The patient had chills, the first night on 01Apr2021 and then sweating a lot the next day on 02Apr2021. On an unknown date in Apr2021, the patient felt like she had the flu, was nauseous and very tired. It was reported that the patient was unknowingly pregnant at the time of vaccination and asking so severe reactions might be possible as combination to the condition. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event arm was so sore, couldn't raise it above shoulder for 4 days was recovered on 04Apr2021 at 15:30. The clinical outcome of the events dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, chills, sweating a lot, felt like she had flu, was nauseous and very tired was recovered on an unknown date in Apr2021.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Nausea, Pain in extremity, Vaccination site pain
Clinical narrative: Sweating; Maternal exposure during pregnancy , gestational age 3 week; Dizzy and lightheaded within 5 minutes of receiving - this lasted about 3 days.; Vaccine burned when being injected; Arm was so sore  ,couldn't raise it above my shoulder for 4 days; Chills; I felt like I had the flu.; Nauseous; So very tired; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0100 and Expiry date was not reported), via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 42-year-old) as dose 1, single dose for COVID-19 immunisation. The patient was pregnant at time of vaccination. Medical history included asthma and fibromyalgia from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient's last menstrual date was on 06Mar2021 and delivery was due on 11Dec2021. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously took sulfamethoxazole (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the patient had received the vaccine during pregnancy there was maternal exposure during pregnancy, first trimester. On 01Apr2021 at 15:30 the patient experienced dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, arm was so sore and couldn't raise it above shoulder for 4 days. The patient had chills, the first night on 01Apr2021 and then sweating a lot the next day on 02Apr2021. On an unknown date in Apr2021, the patient felt like she had the flu, was nauseous and very tired. It was reported that the patient was unknowingly pregnant at the time of vaccination and asking so severe reactions might be possible as combination to the condition. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event arm was so sore, couldn't raise it above shoulder for 4 days was recovered on 04Apr2021 at 15:30. The clinical outcome of the events dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, chills, sweating a lot, felt like she had flu, was nauseous and very tired was recovered on an unknown date in Apr2021.
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Blood pressure decreased, Cough, Heart rate decreased, Hypotension
Clinical narrative: continuous low BP; continuous Low pulse rate; continuous cough and cold badly; continuous cough and cold badly; Subconscious the day i took medicine around 10.30 PM in rest room while using and felt and got hurt in neck; Wife took care and i dont remember anything during that time.; This is a spontaneous report from a contactable consumer or other non-HCP. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Left Arm on an unspecified date (Age of vaccination: Unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 17Apr2021. The patient did not receive any other vaccine in four weeks and no other medications in two weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with covid 19. No known allergies and other medical history reported for the patient. The patient experienced continuous low bp, continuous low pulse rate, continuous cough and cold badly, subconscious the day he took medicine around 10.30 pm in rest room while using and felt and got hurt in neck and wife took care and he dont remember anything during that time. The patient underwent lab tests and procedures which included blood pressure decreased: decreased on an unspecified date. The outcome of all events was not recovered.  No follow up attempts are needed. No further information is expected
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Neck pain
Clinical narrative: continuous low BP; continuous Low pulse rate; continuous cough and cold badly; continuous cough and cold badly; Subconscious the day i took medicine around 10.30 PM in rest room while using and felt and got hurt in neck; Wife took care and i dont remember anything during that time.; This is a spontaneous report from a contactable consumer or other non-HCP. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Left Arm on an unspecified date (Age of vaccination: Unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 17Apr2021. The patient did not receive any other vaccine in four weeks and no other medications in two weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with covid 19. No known allergies and other medical history reported for the patient. The patient experienced continuous low bp, continuous low pulse rate, continuous cough and cold badly, subconscious the day he took medicine around 10.30 pm in rest room while using and felt and got hurt in neck and wife took care and he dont remember anything during that time. The patient underwent lab tests and procedures which included blood pressure decreased: decreased on an unspecified date. The outcome of all events was not recovered.  No follow up attempts are needed. No further information is expected
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: My throat closed up for about 30-40 seconds about 30 minutes after shot; This is a spontaneous report from a non-contactable consumer. This 53-year-old female consumer (patient) reported that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ER 8732) via an unspecified route of administration into the left arm on 27Mar2021 at 04:00 PM (at the age of 53-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks, no treatment. No covid prior vaccination and no covid tested post vaccination. No known allergies. On 27Mar2021 at around 04:30 PM, the patient experienced her throat closed up for about 30-40 seconds about 30 minutes after shot. Outcome of the event was resolved.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol, Limb injury, Poor quality product administered
Clinical narrative: that they used a distilled water instead of solution.; Firmness in my arm; This is a spontaneous report from a contactable consumer (patient). A 64-years-old male patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: ER8732, expiration date: unknown, they told him 2 weeks, but there was no Expiration dates on the sticker that they put on the card, vaccination card), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (at the age of 64 years) as dose 2, single for covid-19 immunisation and water for injection (distilled water [water for injection), via an unspecified route of administration from 27Mar2021 (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for an unspecified indication. Historical Vaccine included first dose of BNT162B2 (LOT number: EN6198) in left arm on 06Mar2021 for covid-19 immunisation. Medical history included back pain, Congestive heart failure, allergy and cholesterol. Concomitant medications included Atorvastatin for blood cholesterol, Baby Aspirin, Alerid for Allergy and Moxicip. On 07Apr2021, the patient stated that vaccination centre used a distilled water instead of solution and had firmness in his arm. Patient stated that the centre called him that they used a distilled water instead of solution. They want him to come back and have a third shot because they said they need to develop the amount of vaccine that they had given. Patient stated a few symptoms, but nothing serious. Had firmness in his arm when they gave him the shots and he thought that was because they injected that too fast and loaded in the muscle and that happens with both shots. So, and that went after one day. The patient underwent lab tests and procedures which included blood cholesterol which was unknown results. At the time of report, outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: Arm pain; Chills; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW169) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies  to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Lofer8733) via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced arm pain and chills for 1 day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain and chills were resolved on 19Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Body height, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Red where I got the shot; bump where I got the shot; hurts where I got the shot; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient). A 27-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported) first dose via an unspecified route of administration on 24Mar2021 (at the age of 27 years) as single for covid-19 immunization. The patient medical history and concomitant medications were not reported.  on an unspecified date of 2021 the patient experienced red bump and it hurts where she got the shot. The patient underwent lab tests and procedures which included body height found to be 5 ft 2 inches or 5ft 3 inches. The outcome of the events was unknown.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: Morning blood sugar reading was 170. This is VERY high; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01580; Expiration Date: Jul2021) via an unspecified route of administration in the left arm on 16Apr2021 at 11:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin glargine/lixisenatide (SOLIQUA), metformin (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732; Expiration Date: Jul2021) via an unspecified route of administration in the left arm on 27Mar2021 at 11:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient also received previously pseudoephedrine hydrochloride (SUDAFED) on an unknown date and experienced allergy. On 17Apr2021 at 08:00, day after the shot, the patient's morning blood sugar reading was 170. This was very high for the patient, as she usually run around 100 or under. On 17Apr2021, the patient underwent blood sugar test and the result was 170 (unspecified unit). The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event morning blood sugar reading was 170, this is very high was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo especially when laying down; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 02:00, the patient experienced vertigo especially when lying down. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo especially when lying down was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pain
Clinical narrative: Injection site redness; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 16Apr2021 at 17:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included tachycardia, allergies, blepharitis and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lactobacillus acidophilus (ACIDOPHILUS) and cetirizine hydrochloride (cetirizine HCL) (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), all the medications were taken for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced Injection site redness and some pain. The patient also reported that pain was mainly when pressure on injection site when lying on arm in bed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site redness and some pain when pressure on injection site was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Muscle spasms
Clinical narrative: stomach muscle spasms - quite strong at times-beginning 16 hours after onset of symptoms; Feeling not well; Chills; Muscle aches; Headache; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 19:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received concomitant medications within 2 weeks of vaccination which are unspecified. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 at 17:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation with no symptoms (reported by the patient). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 15:30, twenty hours after the vaccination, the patient experienced feeling not well, chills, muscle aches, headache, tired. On 16Apr2021, 16 hours after onset of symptoms also had stomach muscle spasms - quite strong at times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling not well, chills, muscle aches, headache, tired were recovered on 17Apr2021.The clinical outcome of the event stomach muscle cramps was recovered on 18Apr2021.  No follow-up attempts are needed. No further information is expected.